(Q36050466)

11 August 2017

1 reference

title

Angiotensin-converting enzyme inhibition in cardiovascular disease: evidence with perindopril (English)

1 reference

11 August 2017

main subject

cardiovascular disease

1 reference

Roberto Ferrari

1

1 reference

11 August 2017

publication date

1 January 2005

1 reference

Expert Review of Cardiovascular Therapy

11 August 2017

published in

1 reference

11 August 2017

volume

3

1 reference

11 August 2017

issue

1

1 reference

11 August 2017

page(s)

15-29

1 reference

Should all patients with coronary disease receive angiotensin-converting-enzyme inhibitors?

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

The pharmacokinetics of perindopril in patients with liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Pharmacokinetic-pharmacodynamic model for perindoprilat regional haemodynamic effects in healthy volunteers and in congestive heart failure patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Perindopril alters vascular angiotensin-converting enzyme, AT(1) receptor, and nitric oxide synthase expression in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Haemodynamic and humoral effects of oral perindopril, an angiotensin converting enzyme inhibitor, in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Long-term treatment with perindopril ameliorates dobutamine-induced myocardial ischemia in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Arterial stiffness and kidney function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Myocardial perfusion during long-term angiotensin-converting enzyme inhibition or beta-blockade in patients with essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Different effect of antihypertensive drugs on conduit artery endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Angiotensin-converting enzyme inhibitors and atherosclerosis: relevance of animal models to human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Losartan and perindopril effects on plasma plasminogen activator inhibitor-1 and fibrinogen in hypertensive type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Perindopril effects on ambulatory blood pressure: relation to sympathetic nervous activity in subjects with diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Acute anti-ischemic effects of perindoprilat in men with coronary artery disease and their relation with left ventricular function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Perindopril postmarketing surveillance: a 12 month study in 47,351 hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Antihypertensive utility of perindopril in a large, general practice-based clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Clinical experience with perindopril in patients nonresponsive to previous antihypertensive therapy: a large US community trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Clinical experience with perindopril in African-American hypertensive patients: a large United States community trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Are angiotensin converting enzyme inhibitors and angiotensin receptor blockers becoming the treatment of choice in African-Americans?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Persistence of anti-hypertensive effect after missed dose of perindopril

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

ABC of heart failure. Management: diuretics, ACE inhibitors, and nitrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Acceptability of perindopril in mild-to-moderate chronic congestive heart failure. Results of a long-term open study in 320 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Comparative haemodynamic responses to the first dose of short- and long-acting ACE inhibitors in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Further evidence that chronic perindopril treatment maintains neurohormonal suppression but does not lower blood pressure in chronic cardiac failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Guidelines for the diagnosis and treatment of chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Comparison of perindopril versus captopril for treatment of acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

The prevalence of treatable left ventricular systolic dysfunction in patients who present with noncardiac vascular episodes: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Blood pressure and stroke: an overview of published reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Reductions in the risks of recurrent stroke in patients with and without diabetes: the PROGRESS Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Perindopril-based blood pressure lowering in individuals with cerebrovascular disease: consistency of benefits by age, sex and region

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Effects of a perindopril-based blood pressure-lowering regimen on disability and dependency in 6105 patients with cerebrovascular disease: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.1.15

21 January 2018

Identifiers

DOI

10.1586/14779072.3.1.15

1 reference

release_asvsdjg7bvglta5knq25qy6acy

11 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/asvsdjg7bvglta5knq25qy6acy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference